https://www.benzinga.com/partner/biotech/25/12/49629043/oncotelic-therapeutics-ceo-discusses-how-being-llm-agnostic-gives-it-a-drug-development-edge
therapeuticsceodiscussesllmagnostic
https://www.prnewswire.com/news-releases/decoy-therapeutics-reaches-global-access-commitment-agreement-to-focus-on-development-of-a-globally-accessible-scalable-peptide-conjugate-manufacturing-platform-302659052.html
/PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of...
global accessdecoytherapeuticsreachescommitment
https://www.prnewswire.com/news-releases/aperture-therapeutics-announces-development-candidate-targeting-cd33-to-restore-microglial-homeostasis-in-ftd-and-als-302620390.html?tc=eml_cleartime
/PRNewswire/ -- Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced...
aperturetherapeuticsannouncesdevelopmentcandidate
https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-expansion-of-its-development-pipeline-additions-to-its-scientific-advisory-board-301715886.html
/PRNewswire/ -- Stuart Therapeutics, Inc. announces that it has expanded its drug development pipeline, adding programs in diabetic macular edema and myopia....
development pipelinestuarttherapeuticsincannounces
https://www.prnewswire.com/news-releases/the-sparx-group-enters-into-a-collaboration-with-arovella-therapeutics-for-the-development-of-cldn18-2-car-inkt-cell-therapy-301952130.html
/PRNewswire/ -- Signifying a monumental step forward in the domain of powered antibody therapies, the SparX Group is thrilled to unveil its strategic...
sparx groupenterscollaborationtherapeutics
https://informaconnect.com/antibody-engineering-therapeutics-asia/speakers/kah-fei-wan-phd/
ANTIBODY ENGINEERING & THERAPEUTICS ASIA | THE ONLY CONFERENCE IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN...
experimental drugantibody engineeringkahfeiwan
https://www.pharmaceutical-technology.com/news/roche-shape-gene-therapy-deal/
Shape Therapeutics has signed a partnership and licence agreement with Roche to develop gene therapy for neuroscience and rare diseases.
sign genedevelopment dealrocheshapetherapeutics
https://www.biospace.com/echo-therapeutics-announces-significant-advance-in-development-of-its-one-piece-needle-free-symphony-tcgm-biosensor-company-plans-clinical-trial-test
echotherapeuticsannouncessignificantadvance
https://www.biospace.com/pliant-therapeutics-appoints-minnie-kuo-as-chief-development-officer
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of...
chief development officerplianttherapeuticsappointsminnie
https://www.technologynetworks.com/genomics/news/clavis-pharma-licenses-lvt-compound-cp4033-to-translational-therapeutics-for-development-in-aggressive-thyroid-tumours-190707
Clavis Pharma and Translational Therapeutics have entered into a strategic licensing agreement regarding the development and commercialization of CP-4033.
clavispharmalicenseslvtcompound
https://www.newswire.com/news/oncology-pharma-licensor-and-co-development-partner-kalos-therapeutics-21133200
Oncology Pharma Inc. (OTCPK:ONPH) is pleased to announce further information from its Licensor, Kalos Therapeutics
development partneroncologypharmalicensorkalos